Every Form 4 that Taylor Devices Inc (TAYD) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow TAYD and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full TAYD filings page.
Taylor Devices, Inc. director Robert Michael Carey reported selling a total of 5,000 shares of Common Stock in open-market transactions. On April 28, 2026, he executed two separate sales at weighted average prices of $57.27 and $55.52 per share.
Footnotes explain that each reported price is a weighted average for multiple trades completed within narrow ranges around those prices, and that detailed price-by-trade information is available upon request. The transactions were reported as direct ownership sales.
TAYLOR DEVICES, INC. Chief Executive Officer Timothy John Sopko received a grant of stock options covering 7,000 shares of Common Stock as compensation. The options have an exercise price of $56.43 per share and expire on April 18, 2036. Following this grant, he holds 7,000 stock options directly.
TAYLOR DEVICES, INC. director Robert Michael Carey received a grant of stock options representing 7,000 shares of common stock. These options were awarded at an exercise price of 56.43 per share and are exercisable into 7,000 shares of common stock. Following this grant, Carey holds 7,000 derivative securities linked to the company’s stock, with an expiration date of April 18, 2036.
TAYLOR DEVICES, INC. Chief Financial Officer Paul Murray Heary reported a compensation-related equity award. He received a grant of stock options covering 7,000 shares of common stock, giving him the right to buy those shares at an exercise price of $56.43 per share.
The options were granted on April 18, 2026 and are scheduled to expire on April 18, 2036. The filing shows no open-market buying or selling of common stock; instead, it records this grant/award acquisition of derivative securities, leaving him with 7,000 stock options after the transaction.
TAYLOR DEVICES, INC. director John Burgess received a grant of stock options on April 18, 2026. He was awarded options for 7,000 shares of common stock with an exercise price of $56.43 per share. After this compensation grant, he holds options for 7,000 shares directly.
Taylor Devices, Inc. director Armenat Fritz Eric reported a compensation-related grant of stock options. He acquired 7,000 Stock Options (Right to Buy) for the company’s common stock on April 18, 2026.
The options carry an exercise price of $56.43 per share and are scheduled to expire on April 18, 2036. After this award, he holds stock options for 7,000 underlying common shares directly.
TAYLOR DEVICES, INC. director John Burgess exercised stock options to acquire 5,000 shares of common stock at an exercise price of $16.40 per share on April 13, 2026. As part of the same event, 1,574 shares of common stock were withheld to satisfy the exercise price or related tax liability, which is a non-market, tax-withholding disposition rather than an open-market sale. Following these transactions, Burgess directly owns 43,426 shares of Taylor Devices common stock.
Taylor Devices, Inc. director F. Eric Armenat reported selling his remaining common shares over two days. On January 22, 2026, he sold 2,800 shares of common stock at a price of $71.773 per share. On January 23, 2026, he executed three additional sales of 528 shares at $72.103 per share, 300 shares at $71.19 per share, and 700 shares at $72.85 per share. Following the final transaction, the Form 4 shows he directly owns 0 shares of Taylor Devices common stock.
Taylor Devices, Inc. director F. Eric Armenat reported an option exercise and related share withholding on 01/21/2026. He exercised a stock option for 5,000 shares of common stock at a price of $9.85 per share, increasing his direct common stock holdings to 5,000 shares immediately after the exercise.
In a separate transaction coded “F” the same day, 672 of those shares were withheld at a value of $73.283 per share, typically reflecting shares surrendered to cover taxes. After these transactions, Armenat directly owned 4,328 shares of Taylor Devices common stock, and the reported 5,000-share stock option position was reduced to zero.
Taylor Devices director F. Eric Armenat reported selling his remaining common shares of the company. The Form 4 shows open-market sales on January 14, 2026 totaling 4,120 shares of Taylor Devices, Inc. common stock.
The first transaction was a sale of 3,820 shares at a weighted average price of $73.21 per share, with individual trade prices ranging from $72.65 to $73.57. A second sale of 300 shares at $74.00 per share is also reported. Following these transactions, Armenat reports 0 shares of Taylor Devices common stock held with direct ownership.
Taylor Devices director F. Eric Armenat reported an option exercise and related share withholding. On January 9, 2026, he exercised a stock option for 5,000 shares of common stock at an exercise price of $11.975 per share, converting a "Stock Option (Right to Buy)" into common stock and reducing his beneficially owned derivative securities to zero. On the same date, 880 shares of common stock were disposed of in a transaction coded "F" at $68.061 per share, reflecting shares withheld to cover obligations associated with the option exercise. After these transactions, he directly owned 4,120 shares of Taylor Devices common stock.